Budd Chiari syndrome and V617F/JAK 2 mutation linked with the myeloproliferative disorders

J Gastrointestin Liver Dis. 2010 Mar;19(1):108-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Budd-Chiari Syndrome / diagnosis
  • Budd-Chiari Syndrome / enzymology
  • Budd-Chiari Syndrome / genetics*
  • Budd-Chiari Syndrome / therapy
  • Humans
  • Janus Kinase 2 / genetics*
  • Mutation*
  • Myeloproliferative Disorders / diagnosis
  • Myeloproliferative Disorders / enzymology
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / therapy
  • Predictive Value of Tests
  • Recurrence
  • Time Factors
  • Treatment Outcome

Substances

  • JAK2 protein, human
  • Janus Kinase 2